My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
March 2012
Your Colleagues
Check Out “My IDSA” for Latest Member News

Find the latest membership news on “My IDSA” on the IDSA website, including new IDSA members, the April 2 deadline to submit nominations for the 2012 IDSA Society Awards, and an update on advance access to new articles in The Journal of Infectious Diseases and Clinical Infectious Diseases.

Are you a member on the move? Do you know someone who is? Contact Stephanie Cox at scox@idsociety.org so that we can announce it to our membership.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Patient Care and Science
EIN Update: A Complex Case of Multidrug Resistant P. aeruginosa
IDSA, SHEA, PIDS Outline National Approach to Antimicrobial Stewardship
C. difficile Infections Growing Threat Across Medical Settings
Drug Approvals, Recalls, Adverse Events Update
Global ID
Highlights from CROI 2012 Conference
New Combo Drug Trial Has Potential to Transform TB Treatment
Global Health Community Applauds Nomination of Jim Yong Kim, MD, PhD, for World Bank
Policy and Advocacy
Patient-Centered Outcomes Research Agenda Should Include ID
Your Colleagues
Check Out “My IDSA” for Latest Member News
Education & Resources
Advance Access to JID and CID Manuscripts
New Pediatric ID Journal Now Available
Top Stories
From the President: What’s on Tap for IDWeek 2012, Oct. 17-21
New Guideline for Acute Bacterial Rhinosinusitis Now Available
IDSA Proposes New Pathway for Antibiotic Approval,Action from Members Needed
IDSA Journal Club

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.